| abstract |
The inventors have disclosed compositions comprising vitamin D (cholecalciferol and / or ergocalciferol) and 25-OH D3 (calciferdiol) as well as the use of these compositions in humans to provide at least a concentration of vitamin D. Disclosed are uses for influencing bioavailability, metabolism or efficacy. Also disclosed are the form and dosage of the composition, as well as a method of making the spray dried formulation. |